No headlines found.
No press releases found.
No news found.
Invests in stocks in the S&P MidCap 400 Growth Index composed of the growth companies in the S&P 400. Focuses on closely tracking the index s return which is considered a gauge of overall U.S. mid-cap growth stock returns. Offers high potential for investment growth; share value rises and falls more sharply than that of funds holding bonds. More appropriate for long-term goals where your money s growth is essential.
Vanguard S&P Mid-Cap 400 Growth ETF trades on the ARCA stock market under the symbol IVOG.
As of March 20, 2025, IVOG stock price declined to $105.00 with 18,892 million shares trading.
IVOG has a beta of 1.14, meaning it tends to be more sensitive to market movements. IVOG has a correlation of 0.70 to the broad based SPY ETF.
IVOG has a market cap of $1.05 billion. This is considered a Small Cap stock.
In the last 3 years, IVOG traded as high as $124.73 and as low as $76.40.
IVOG has underperformed the market in the last year with a return of -3.6%, while the SPY ETF gained +10.7%. In the last 3 month period, IVOG fell short of the market, returning -7.3%, while SPY returned -2.9%. However, in the most recent 2 weeks IVOG has outperformed the stock market by returning -2.6%, while SPY returned -3.0%.
IVOG support price is $104.12 and resistance is $107.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IVOG shares will trade within this expected range on the day.